NCT00037128View on ClinicalTrials.gov

Study of GL701 in Men With Systemic Lupus Erythematosus

PHASE3UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 1998

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

GL701

Trial Locations (1)

94063

Genelabs Technologies, Inc., Redwood City

Sponsors
All Listed Sponsors
lead

Genelabs Technologies

INDUSTRY